deltatrials
Unknown NA INTERVENTIONAL 2-arm NCT02594501

Randomized Trial of COBRA PzF Stenting to Reduce Duration of Triple Therapy (COBRA-REDUCE)

COBRA PzF Stenting to Reduce the Duration of Triple Therapy in Patients Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention

Sponsor: CeloNova BioSciences, Inc.

Updated 17 times since 2017 Last updated: Oct 23, 2020 Started: Feb 5, 2016 Primary completion: May 31, 2021 Completion: Nov 30, 2021
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02594501, this NA trial focuses on Angina, Stable and Angina, Unstable and remains ongoing. Sponsored by CeloNova BioSciences, Inc., it has been updated 17 times since 2016, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshot~Feb 2017 – ~Mar 2017 · 28 days · monthly snapshot~Mar 2017 – ~Nov 2017 · 8 months · monthly snapshot~Nov 2017 – ~Jun 2018 · 7 months · monthly snapshot~Jun 2018 – ~Sep 2018 · 3 months · monthly snapshot~Sep 2018 – ~Dec 2018 · 3 months · monthly snapshot~Dec 2018 – ~Jan 2019 · 31 days · monthly snapshot~Jan 2019 – ~Feb 2020 · 13 months · monthly snapshot~Feb 2020 – ~Apr 2020 · 2 months · monthly snapshot~Apr 2020 – ~Jul 2020 · 3 months · monthly snapshot~Jul 2020 – ~Nov 2020 · 4 months · monthly snapshot~Nov 2020 – ~Jan 2021 · 2 months · monthly snapshot~Jan 2021 – ~Nov 2022 · 22 months · monthly snapshot~Nov 2022 – ~Jul 2024 · 20 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshot~Sep 2025 – present · 10 months · monthly snapshot

Change History

17 versions recorded
  1. Sep 2025 — Present [monthly]

    Unknown NA

  2. Sep 2024 — Sep 2025 [monthly]

    Unknown NA

  3. Jul 2024 — Sep 2024 [monthly]

    Unknown NA

    Status: Unknown StatusUnknown

  4. Nov 2022 — Jul 2024 [monthly]

    Unknown Status NA

    Status: Active Not RecruitingUnknown Status

  5. Jan 2021 — Nov 2022 [monthly]

    Active Not Recruiting NA

Show 12 earlier versions
  1. Nov 2020 — Jan 2021 [monthly]

    Active Not Recruiting NA

  2. Jul 2020 — Nov 2020 [monthly]

    Active Not Recruiting NA

    Status: RecruitingActive Not Recruiting

  3. Apr 2020 — Jul 2020 [monthly]

    Recruiting NA

  4. Feb 2020 — Apr 2020 [monthly]

    Recruiting NA

  5. Jan 2019 — Feb 2020 [monthly]

    Recruiting NA

  6. Dec 2018 — Jan 2019 [monthly]

    Recruiting NA

  7. Sep 2018 — Dec 2018 [monthly]

    Recruiting NA

  8. Jun 2018 — Sep 2018 [monthly]

    Recruiting NA

  9. Nov 2017 — Jun 2018 [monthly]

    Recruiting NA

  10. Mar 2017 — Nov 2017 [monthly]

    Recruiting NA

  11. Feb 2017 — Mar 2017 [monthly]

    Recruiting NA

  12. Jan 2017 — Feb 2017 [monthly]

    Recruiting NA

    First recorded

Feb 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • CeloNova BioSciences, Inc.
Data source: CeloNova BioSciences, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .